Clinical Trial Update: Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of Umbilical Cord Mesenchymal Stem Cells for subacute ischemic stroke is registered, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shanghai IxCell Biotechnology Co., LTD | Conditions: Ischemic Stroke | Phase 2 | Status: NOT_YET_RECRUITING